These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 29080546

  • 21. Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study.
    Weeda ER, Bishu KG, Ward R, Axon RN, Taber DJ, Gebregziabher M.
    BMC Cardiovasc Disord; 2020 Oct 15; 20(1):449. PubMed ID: 33059602
    [Abstract] [Full Text] [Related]

  • 22. Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study.
    Gamboa CM, Colantonio LD, Brown TM, Carson AP, Safford MM.
    J Am Heart Assoc; 2017 May 10; 6(5):. PubMed ID: 28490523
    [Abstract] [Full Text] [Related]

  • 23. Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies.
    Knickelbine T, Lui M, Garberich R, Miedema MD, Strauss C, VanWormer JJ.
    J Clin Lipidol; 2016 May 10; 10(5):1182-7. PubMed ID: 27678435
    [Abstract] [Full Text] [Related]

  • 24. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
    Singh A, Gupta A, Collins BL, Qamar A, Monda KL, Biery D, Lopez JAG, de Ferranti SD, Plutzky J, Cannon CP, Januzzi JL, Di Carli MF, Nasir K, Bhatt DL, Blankstein R.
    J Am Coll Cardiol; 2019 May 21; 73(19):2439-2450. PubMed ID: 31097165
    [Abstract] [Full Text] [Related]

  • 25. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.
    Zafrir B, Shapira C, Lavie G, Halon DA, Flugelman MY.
    J Clin Lipidol; 2016 May 21; 10(6):1338-1343. PubMed ID: 27919350
    [Abstract] [Full Text] [Related]

  • 26. Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia.
    Agarwala A, Bekele N, Deych E, Rich MW, Hussain A, Jones LK, Sturm AC, Aspry K, Nowak E, Ahmad Z, Ballantyne CM, Goldberg AC.
    J Am Heart Assoc; 2021 Sep 07; 10(17):e020890. PubMed ID: 34431361
    [Abstract] [Full Text] [Related]

  • 27. Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.
    Saltijeral A, Pérez de Isla L, Alonso R, Muñiz O, Díaz-Díaz JL, Fuentes F, Mata N, de Andrés R, Díaz-Soto G, Pastor J, Pinilla JM, Zambón D, Pinto X, Badimón L, Mata P, SAFEHEART Investigators.
    Rev Esp Cardiol (Engl Ed); 2017 Jun 07; 70(6):444-450. PubMed ID: 27913073
    [Abstract] [Full Text] [Related]

  • 28. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.
    Nanna MG, Navar AM, Zakroysky P, Xiang Q, Goldberg AC, Robinson J, Roger VL, Virani SS, Wilson PWF, Elassal J, Lee LV, Wang TY, Peterson ED.
    JAMA Cardiol; 2018 Aug 01; 3(8):739-748. PubMed ID: 29898219
    [Abstract] [Full Text] [Related]

  • 29. High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry.
    Béliard S, Boccara F, Cariou B, Carrié A, Collet X, Farnier M, Ferrières J, Krempf M, Peretti N, Rabès JP, Varret M, Vimont A, Charrière S, Bruckert E, French FH Registry group.
    Atherosclerosis; 2018 Oct 01; 277():334-340. PubMed ID: 30270068
    [Abstract] [Full Text] [Related]

  • 30. Target achievement with maximal statin-based lipid-lowering therapy in Korean patients with familial hypercholesterolemia: A study supported by the Korean Society of Lipid and Atherosclerosis.
    Oh J, Lee CJ, Kim DI, Rhee MY, Lee BK, Ahn Y, Cho BR, Woo JT, Hur SH, Jeong JO, Jang Y, Lee SH.
    Clin Cardiol; 2017 Dec 01; 40(12):1291-1296. PubMed ID: 29243274
    [Abstract] [Full Text] [Related]

  • 31. Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.
    Schmidt N, Dressel A, Grammer TB, Gouni-Berthold I, Julius U, Kassner U, Klose G, König C, Koenig W, Otte B, Parhofer KG, Reinhard W, Schatz U, Schunkert H, Steinhagen-Thiessen E, Vogt A, Laufs U, März W.
    Atherosclerosis; 2018 Oct 01; 277():314-322. PubMed ID: 30270065
    [Abstract] [Full Text] [Related]

  • 32. Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014.
    Gu A, Kamat S, Argulian E.
    Diabetes Res Clin Pract; 2018 May 01; 139():1-10. PubMed ID: 29476887
    [Abstract] [Full Text] [Related]

  • 33. Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial.
    Newman JD, Alexander KP, Gu X, O'Brien SM, Boden WE, Govindan SC, Senior R, Moorthy N, Rezende PC, Demkow M, Lopez-Sendon JL, Bockeria O, Pandit N, Gosselin G, Stone PH, Spertus JA, Stone GW, Fleg JL, Hochman JS, Maron DJ.
    Circ Cardiovasc Qual Outcomes; 2019 Nov 01; 12(11):e006002. PubMed ID: 31718297
    [Abstract] [Full Text] [Related]

  • 34. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice.
    Vohnout B, Fábryová Ľ, Klabník A, Kadurová M, Bálinth K, Kozárová M, Bugáňová I, Sirotiaková J, Rašlová K.
    Atherosclerosis; 2018 Oct 01; 277():323-326. PubMed ID: 30270066
    [Abstract] [Full Text] [Related]

  • 35. Latvian registry of familial hypercholesterolemia: The first report of three-year results.
    Latkovskis G, Saripo V, Gilis D, Nesterovics G, Upena-Roze A, Erglis A.
    Atherosclerosis; 2018 Oct 01; 277():347-354. PubMed ID: 30270070
    [Abstract] [Full Text] [Related]

  • 36. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
    Ravnskov U, de Lorgeril M, Kendrick M, Diamond DM.
    Med Hypotheses; 2018 Dec 01; 121():60-63. PubMed ID: 30396495
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study.
    Blom DJ, Almahmeed W, Al-Rasadi K, Azuri J, Daclin V, Kayikcioglu M, Mercier F, Ruiz AJ, Santos RD, ICLPS study group.
    J Clin Lipidol; 2019 Dec 01; 13(4):594-600. PubMed ID: 31208705
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.